These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28890884)

  • 1. Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.
    Elhamamsy AR; El Sharkawy MS; Zanaty AF; Mahrous MA; Mohamed AE; Abushaaban EA
    Int J Mol Cell Med; 2017; 6(2):77-86. PubMed ID: 28890884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
    Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
    Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
    Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-92a as a marker of treatment response and survival in adult acute myeloid leukemia patients.
    Rashed RA; Hassan NM; Hussein MM
    Leuk Lymphoma; 2020 Oct; 61(10):2475-2481. PubMed ID: 32536234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma miR-92a-2 as a biomarker for small cell lung cancer.
    Yu Y; Zuo J; Tan Q; Zar Thin K; Li P; Zhu M; Yu M; Fu Z; Liang C; Tu J
    Cancer Biomark; 2017; 18(3):319-327. PubMed ID: 28106539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
    Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
    Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.
    Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N
    Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Su XY; Zhao Q; Ke JM; Wu DH; Zhu X; Lin J; Deng ZQ
    Cancer Manag Res; 2020; 12():11871-11881. PubMed ID: 33239917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and Clinical Significance of Serum MiR-370 and MiR-203 in Patients with Acute Myeloid Leukemia].
    Ye LH; Ma X; Xu SC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):445-449. PubMed ID: 33812413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a.
    Ohyashiki JH; Umezu T; Kobayashi C; Hamamura RS; Tanaka M; Kuroda M; Ohyashiki K
    BMC Res Notes; 2010 Dec; 3():347. PubMed ID: 21182798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.
    Hong Z; Zhang R; Qi H
    Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
    Fang Z; Wang X; Wu J; Xiao R; Liu J
    Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial microparticles and
    Zhang Y; Cheng J; Chen F; Wu C; Zhang J; Ren X; Pan Y; Nie B; Li Q; Li Y
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28213360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study.
    Wang X; Zhi X; Zhang Y; An G; Feng G
    J Thorac Dis; 2016 Jul; 8(7):1645-52. PubMed ID: 27499953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
    Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
    Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin resistance may be identified by miR-92a in plasma combined with platelet distribution width.
    Binderup HG; Houlind K; Madsen JS; Brasen CL
    Clin Biochem; 2016 Oct; 49(15):1167-1172. PubMed ID: 27208561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia.
    Xue Y; Ge Y; Kang M; Wu C; Wang Y; Rong L; Fang Y
    BMC Cancer; 2019 Jan; 19(1):109. PubMed ID: 30700251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.